All News

2070 articles, sorted by publication time.

Biopharma · eu

European Drug Review’s June Meeting Opens the Door With One Hand and Hits the Brakes With the Other

Six new medicines were recommended for approval, moving once-weekly basal insulin, an influenza vaccine for older adults, and a rare-disease neurology drug closer to market; but negative opinions for a cell therapy and microbiome products also underscored that innovative platforms cannot bypass the thresholds of clinical credibility and manufacturing quality.